Article

Bbarrons.com on 2020-05-12 17:15

AbbVie Stock Has 15% Upside, J.P. Morgan Analyst Says

After closing its acquisition of Allergan, AbbVie has a valuation that “remains at steep discount” to its pharmaceutical peers, says J.P. Morgan ...

Related news

BAbbVie Stock Has More Upside, Analyst Says barrons.com
Denmark
BBuy Lilly, AbbVie and Merck, J.P. Morgan Says barrons.com
AbbVie Stock Has More Upside?Forbes
China
MValeant’s stock plunges, but J.P. Morgan stays bullish marketwatch.com
MGE's stock pares gains; J.P. Morgan analyst gets more bearish marketwatch.com
Pfizer Stock Vs. AbbVie Forbes
Peers , Alaska , California , Los Angeles
BAbbVie Stock Is ‘Unsustainably Cheap’ After Allergen Acquisition barrons.com
Stock Island
MTeva's stock drops after J.P. Morgan downgrades to rare bearish rating marketwatch.com
MFogo de Chao's stock rallies after J.P. Morgan upgrades on attractive upside marketwatch.com
Brazil
What’s Happening With AbbVie Stock?Forbes
Peers
What’s Driving AbbVie Stock Higher?Forbes
Peers
MAT&T stock falls after J.P. Morgan analyst says he prefers Verizon marketwatch.com
BQualcomm Stock Called a ‘Top Pick’ by J.P. Morgan Analyst for Its 5G Potential barrons.com
Wall Street
MTesla's stock bounces, as long-time bearish analyst at J.P. Morgan lifts price target marketwatch.com
MGE's stock slips after bearish J.P. Morgan analyst questions focus on deal 'headlines'marketwatch.com
MCoinbase stock gets a boost from J.P. Morgan, as analyst recommends investors buy marketwatch.com
Wall Street
MGE's stock falls for 3rd-straight session; bearish J.P. Morgan analyst says it's 'significantly overvalued'marketwatch.com
MGE’s stock a rare Dow decliner after J.P. Morgan analyst gets even more bearish marketwatch.com
MGeneral Electric's stock falls after J.P. Morgan analyst reiterates bearish view marketwatch.com
MGoPro stock downgraded to neutral at J.P. Morgan; analyst cites 'tough road back to profitability'marketwatch.com